We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.98B
AUM Growth
-$931M
Cap. Flow
-$600M
Cap. Flow %
-15.05%
Top 10 Hldgs %
60.92%
Holding
66
New
9
Increased
17
Reduced
15
Closed
22

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$71.2M
2
HUM icon
Humana
HUM
+$68.6M
3
CI icon
Cigna
CI
+$60.7M
4
UBER icon
Uber
UBER
+$57.6M
5
CNC icon
Centene
CNC
+$55.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$324M
2
DOCN icon
DigitalOcean
DOCN
+$111M
3
THC icon
Tenet Healthcare
THC
+$96.7M
4
EXPE icon
Expedia Group
EXPE
+$91.1M
5
KNX icon
Knight Transportation
KNX
+$76.3M

Sector Composition

Rank Sector Weight
1 Healthcare 45.27%
2 Technology 18.54%
3 Industrials 11.89%
4 Consumer Discretionary 9.84%
5 Communication Services 4.2%

No holdings matched the selected filter criteria.

1 2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Glenview Capital Management held 66 positions worth $3.98B, down 19% from $4.91B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Glenview Capital Management withdrew a net $600M in Q1 2026, closing 22 positions and reducing 15 holdings. Its most notable exit was Expedia Group, an estimated $91.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Humana worth $58.1M.

  • Glenview Capital Management's largest Q1 2026 buy was Humana: 334,892 shares worth $58.1M.
  • Glenview Capital Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $71.2M increase.
  • Glenview Capital Management's biggest Q1 2026 reduction was Teva Pharmaceuticals, cutting an estimated $324M.
  • Glenview Capital Management fully exited Expedia Group in Q1 2026, selling an estimated $91.1M.
  • Glenview Capital Management's ten largest holdings make up 61% of its $3.98B portfolio in Q1 2026.
  • Glenview Capital Management opened 9 new positions and closed 22 in Q1 2026.
  • Glenview Capital Management's portfolio value fell 19% quarter-over-quarter to $3.98B.

Based on Glenview Capital Management's 13F filing for Q1 2026, filed 15 May 2026.